Last updated: October 8, 2014
Sponsor: University of Roma La Sapienza
Overall Status: Completed
Phase
3
Condition
Heart Disease
Hypercholesterolemia
Carotid Artery Disease
Treatment
N/AClinical Study ID
NCT02260453
University "La Sapienza" Rome
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
indication for carotid endarterectomy
no clinical sign or history of ischemic heart disease
no electrical signs of cardiac ischemia
left ventricular ejection fraction >50% at transthoracic echocardiogram.
Exclusion
Exclusion Criteria:
disabling stroke (mRS ≥3)
non atherosclerotic carotid disease
severe intracranial carotid artery stenosis
contra-indications to heparin, aspirin or clopidogrel.
Study Design
Total Participants: 426
Study Start date:
January 01, 2005
Estimated Completion Date:
June 30, 2012